Answers are grounded in this paper and cite their sources.
Integration of single-cell RNA sequencing and flow cytometry identifies novel immune subsets in patients, suggesting diagnostic advances.
By integrating scRNA/BCR-seq and flow cytometry, we identified three novel immune cell subsets in PBMCs of AIP patients and confirmed their diagnostic and prognostic value. A flow cytometry-derived nomogram based on these subsets provides a novel tool for differentiating patients with AIP from those with PDAC.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: